Skip to main content
Andrew Pippas, MD, Oncology, Columbus, GA

Andrew W Pippas MD


Medical Director and Director of Clinical Oncology at Georgia Center

Join to View Full Profile
  • 1831 5th AveColumbus, GA 31904

  • Phone+1 706-320-8780

  • Fax+1 706-660-2583

Are you Dr. Pippas?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andrew Pippas, MD is an oncologist in Columbus, Georgia. He is currently licensed to practice medicine in Georgia, Florida, and North Carolina.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1986 - 1989
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1980

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2003 - 2025
  • FL State Medical License
    FL State Medical License 1995 - 2004
  • NC State Medical License
    NC State Medical License 1993 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • With This Grant Renewal Comes New Initiatives and Grant Aims to Further Expand Cancer Research to a Broader Population and Include Underserved Populations in Cancer Research:
    With This Grant Renewal Comes New Initiatives and Grant Aims to Further Expand Cancer Research to a Broader Population and Include Underserved Populations in Cancer Research:July 16th, 2019
  • Why Precision Medicines for Oncology Demands Precision Engagement
    Why Precision Medicines for Oncology Demands Precision EngagementMay 24th, 2019